Key result
In the EU-CaRE study, the socioeconomic gap in exercise capacity (VO2peak) widened following cardiac rehabilitation among 1,626 elderly patients.
Answers are grounded in this paper and cite their sources.
Socioeconomic status significantly impacts baseline fitness and outcomes in cardiac rehabilitation, highlighting the need for individualized approaches to address inequity in cardiovascular health.
The importance of cardiac rehabilitation (CR) is well established and prominently referenced in current guidelines.1,2 Even though the current evidence is overwhelming, and the level of recommendation and class of evidence is as high as it can be (1A), CR is still underused in many countries. Indeed, the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology only recently published the ExTraHF (Exercise Training in Heart Failure) survey, indicating significant differences in the implementation of exercise training programs for heart failure patients. Poorest availability of exercise training could be seen in southern, eastern and extra-European countries – that is, countries with lower socioeconomic status.3 The SCORE risk tool that estimates 10-year risk for fatal cardiovascular events in Europe by gender, age, systolic blood pressure, total cholesterol and smoking status further differentiates European countries regarding higher and lower cardiovascular risk. Low-risk countries mostly represent countries with high socioeconomic standards (Andorra, Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Monaco, the Netherlands, Norway, Portugal, San Marino, Slovenia, Spain, Sweden, Switzerland and the UK). However, the high-risk countries, almost exclusively represent countries with lower socioeconomic standards (Albania, Algeria, Armenia, Azerbaijan, Belarus, Bulgaria, Egypt, Georgia, Kazakhstan, Kyrgyzstan, Latvia, North Macedonia, Moldova (Republic of), Russian Federation, Syrian Arab Republic, Tajikistan, Turkmenistan, Ukraine and Uzbekistan).1 These observations – namely, that socioeconomic status is a strong predictor of cardiovascular health – were recently confirmed in an analysis of the PURE (Prospective Urban Rural Epidemiology) study.4 Cardiovascular risk factors attributed to mortality differed in low- and middle-income countries (poor diet, household air pollution, poor education) as compared to high-income countries. Interestingly, behavioral risk factors (i.e. tobacco use, alcohol, diet, physical activity and sodium intake) contributed most to deaths (26.3% of the population-attributable fractions (PAFs)), although the single largest risk factor was low education level (12.5% of the PAF).4 Patients that are enrolled to CR usually have a multitude of cardiovascular risk factors, and a comprehensive CR with emphasis on exercise training offers a great opportunity to manage these risk factors in the long term. Low socioeconomic status, however, is obviously difficult to “manage”. There is no drug available to increase socioeconomic status, and yet it is even more important in the management of our patients. Several recent studies have addressed this emerging aspect in CR. Hinde et al. showed that increasing CR uptake is cost-effective and can also be implemented to reduce known socioeconomic inequalities.5 The authors produced tools with which policymakers and commissioners can encourage greater utilization of CR services by using an estimation of potential population health gains and justifiable expenditure.5 Smoking appeared to be the driving force behind educational differences in premature cardiovascular disease mortality in a large Norwegian study from the 1930s to 1950s birth cohorts for men and in the two recent birth cohorts for women.6 Ariansen et al. suggested that strategies for smoking prevention and cessation might have the strongest impact for reducing educational inequality in premature cardiovascular disease mortality.6 In a French study by Neufcourt et al., hypertension prevalence varied greatly among French regions and this was partly explained by known lifestyle and socioeconomic factors.7 Finally, also among one-year survivors of a first myocardial infarction, first recurrent manifestation of atherosclerotic cardiovascular disease was predicted by disposable income, level of education and marital status, in a large Swedish cohort study. Ohm et al. report that the association between disposable income and first recurrent manifestation of atherosclerotic cardiovascular disease was independent of secondary preventive treatment, but they also suggest that further study on causal pathways is needed.8 In line with these observations, Kjesbu et al. present convincing data on this topic in the present issue of the journal.9 The observational EU-CaRE (EUropean study on effectiveness and sustainability of current Cardiac Rehabilitation programs in the Elderly) study was a prospective study of eight CR sites in seven European countries (Denmark, France, Germany, the Netherlands, Italy, Spain and Switzerland). The investigators enrolled patients of ≥65 years of age with coronary heart disease or after heart valve surgery, and comprehensively evaluated the subjects at baseline, at end-of-CR and at one-year follow-up. Educational level, as a marker for socioeconomic status, was divided into basic, intermediate and high, according to the socioeconomic status, exercise capacity (peak oxygen consumption (VO2peak)) and, as secondary endpoints, cardiovascular risk factors, medical treatment and scores for depression, anxiety and quality of life were evaluated. The authors report on 1626 patients, of whom 28% had basic, 48% intermediate and 24% high education. A total of 1515 (93.2%) and 1448 (89.1%) patients were available for follow-up analyses at end-of-CR and one-year, respectively. The authors could show that patients with basic education were older and more often female. Even at baseline, a socioeconomic gradient in VO2peak, lifestyle-related cardiovascular risk factors, anxiety, depression and quality of life was present. This socioeconomic gap in VO2peak even increased following CR (p for interaction < 0.001). In conclusion, the authors found a strong socioeconomic gradient in VO2peak and cardiovascular risk factors that was unaffected or even worsened after CR. These findings are impressive and relevant for several reasons. On the positive side, this study confirms that evidence-based medication to improve cardiovascular risk profile for our patients referred to CR is maintained during CR, irrespective of socioeconomic status. This is reassuring and strengthens the role of CR. However, the socioeconomic gap that this study showed is concerning. Even at baseline, patients with basic socioeconomic status were less fit, and the socioeconomic gap with respect to fitness even increased during CR. Likewise, several cardiovascular risk factors, and also anxiety, depression and quality of life, showed a less favorable outcome after CR in patients with basic socioeconomic status. Consequently, special efforts are warranted to specifically support patients in CR with low socioeconomic status in order to also benefit from CR. We have previously shown that subjects enrolled to CR studies do not always represent the real world, with females, elderly, patients at advanced stages of their disease and those with more comorbidities underrepresented.10 Socioeconomic status is not consistently mentioned in CR studies; however, most likely, the selection bias also applies to socioeconomic status. Also, in this study, the authors themselves acknowledge this issue: Great care was taken to identify all eligible patients in the inclusion process as we are well aware of a socioeconomic inequality in CR referral and uptake. We however acknowledge the risk of selection bias entraining a risk of type 2 error, underestimating the socioeconomic difference in an elderly CR population. (p. 7).9 In other words, if the socioeconomic gap is present in the enrolled patients that are likely to be of higher socioeconomic status than those not enrolled to CR, the gap between those patients not even enrolled to CR is likely to be even greater. Another interesting aspect is that all participating centers of the study are located in low-risk countries according to the SCORE risk tool (countries of participating centers of the EU-CaRE study shown in italics above). All included patients of this study live in low-risk countries, but, as shown by Kjesbu et al., there exists a clinically relevant socioeconomic gradient within these countries.9 We can only speculate that a socioeconomic gradient would also exist and might well be even more pronounced in high-risk countries. Research to counteract the devastating consequences of uncontrolled cardiovascular risk factors, low exercise capacity and weak implementation of CR is desperately needed, especially in high-risk countries. Interestingly, Kjesbu et al. report no difference in drop-out rates between socioeconomic strata – something that has been reported previously.11 All these aspects urge us to optimize accessibility, adherence and drop-out rates in CR, especially in patients with basic socioeconomic status. CR works, but only if patients adhere. Financial incentives have previously been suggested to increase adherence in CR. In a recent US-based study, 130 individuals enrolled in Medicaid with a CR-qualifying cardiac event with low socioeconomic status were randomized 1:1 to receive financial incentives on an escalating schedule (US$4 to US$50) for completing CR sessions or to receive usual care. Patients randomized to the incentive condition completed more sessions (22.4 vs 14.7, respectively; p = 0.013) and were almost twice as likely to complete CR (55.4% vs 29.2%, respectively; p = 0.002) as controls. Incentivized patients were also more likely to experience improvements in executive function (p < 0.001).12 Also, gamification could be a possibility to increase adherence in CR, which was shown to also work in elderly subjects with heart failure.13 Taken together, socioeconomic status matters, on a population level, not only in cardiovascular risk estimation but also in CR. Obviously, there is no specific “treatment” to tackle this underestimated risk factor, and, as in most other clinical problems, we know that one size does not fit for all patients. Individualized or personalized medicine is present everywhere today. As a preventive cardiology community, we have to start to consider how to individualize CR to the special needs of our individual patients, also according to the different socioeconomic needs of our patients. Or, as Kjesbu et al. so brilliantly put it, to address inequity in cardiovascular health, the individual adaption of CR according to socioeconomic needs should be considered.9 The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The author(s) received no financial support for the research, authorship, and/or publication of this article.
No takes yet. Share an insight, caveat, or question.
Niederseer et al. (2020) conducted an editorial in Cardiovascular disease. Socioeconomic status was evaluated. In the EU-CaRE study, the socioeconomic gap in exercise capacity (VO2peak) widened following cardiac rehabilitation among 1,626 elderly patients.
Synapse has enriched 10 related papers. Consider them for comparative context: